Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan (vol 107, pg 656, 2018)

被引：1

作者：

Ueda, Yasutaka ^{[1
,2
]}

Obara, Naoshi ^{[2
,3
]}

Yonemura, Yuji ^{[2
,4
]}

Noji, Hideyoshi ^{[2
,5
]}

Masuko, Masayoshi ^{[6
]}

Seki, Yoshinobu ^{[7
,8
]}

Wada, Katsuya ^{[9
]}

Matsuda, Takahisa ^{[10
]}

Akiyama, Hirozumi ^{[10
]}

Ikezoe, Takayuki ^{[2
,5
]}

Chiba, Shigeru ^{[2
,11
]}

Kanda, Yoshinobu ^{[2
,12
]}

Kawaguchi, Tatsuya ^{[2
,13
,14
]}

Shichishima, Tsutomu ^{[2
,5
]}

Nakakuma, Hideki ^{[2
,15
]}

Okamoto, Shinichiro ^{[2
,16
]}

Nishimura, Jun-ichi ^{[1
,2
]}

Kanakura, Yuzuru ^{[1
,2
]}

Ninomiya, Haruhiko ^{[2
,17
]}

机构：

[1] Osaka Univ, Dept Hematol & Oncol, Grad Sch Med, Suita, Osaka, Japan

[2] Japan PNH Study Grp, Tokyo, Japan

[3] Univ Tsukuba, Dept Hematol, Tsukuba, Ibaraki, Japan

[4] Kumamoto Univ Hosp, Dept Transfus Med & Cell Therapy, Kumamoto, Japan

[5] Fukushima Med Univ, Dept Hematol, Fukushima, Japan

[6] Niigata Univ Hosp, Dept Stem Cell Transplantat, Niigata, Japan

[7] Niigata Prefectural Shibata Hosp, Dept Hematol, Shibata, Japan

[8] Niigata Univ, Uonuma Inst Community Med, Dept Hematol, Med & Dent Hosp, Minami Uonuma, Japan

[9] Matsushita Mem Hosp, Dept Hematol, Moriguchi, Osaka, Japan

[10] Alex Pharma GK, Tokyo, Japan

[11] Univ Tsukuba, Dept Hematol, Fac Med, Tsukuba, Ibaraki, Japan

[12] Jichi Med Univ, Div Hematol, Shimotsuke, Japan

[13] Kumamoto Univ, Dept Hematol, Kumamoto, Japan

[14] Kumamoto Univ, Dept Infect Dis, Kumamoto, Japan

[15] Kagoshima Tokusyukai Hosp, Kagoshima, Japan

[16] Keio Univ, Div Hematol, Dept Med, Sch Med, Tokyo, Japan

[17] Univ Tsukuba, Dept Med Sci, Fac Med, Tsukuba, Ibaraki, Japan

来源：

INTERNATIONAL JOURNAL OF HEMATOLOGY | 2018年 / 108卷 / 02期

关键词：

D O I：

10.1007/s12185-018-2486-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In the original publication of this article, Tables 2, 3 and 4 were published incorrectly. The corrected tables 2, 3 and 4 are given in the following pages.

引用

页码：233 / 235

页数：3

共 50 条

[1] Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan
Yasutaka Ueda
Naoshi Obara
Yuji Yonemura
Hideyoshi Noji
Masayoshi Masuko
Yoshinobu Seki
Katsuya Wada
Takahisa Matsuda
Hirozumi Akiyama
Takayuki Ikezoe
Shigeru Chiba
Yoshinobu Kanda
Tatsuya Kawaguchi
Tsutomu Shichishima
Hideki Nakakuma
Shinichiro Okamoto
Jun-ichi Nishimura
Yuzuru Kanakura
Haruhiko Ninomiya
[J]. International Journal of Hematology, 2018, 107 : 656 - 665
[2] Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan
Ueda, Yasutaka
Obara, Naoshi
Yonemura, Yuji
Noji, Hideyoshi
Masuko, Masayoshi
Seki, Yoshinobu
Wada, Katsuya
Matsuda, Takahisa
Akiyama, Hirozumi
Ikezoe, Takayuki
Chiba, Shigeru
Kanda, Yoshinobu
Kawaguchi, Tatsuya
Shichishima, Tsutomu
Nakakuma, Hideki
Okamoto, Shinichiro
Nishimura, Jun-ichi
Kanakura, Yuzuru
Ninomiya, Haruhiko
[J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (06) : 656 - 665
[3] Effects of Eculizumab Treatment on the Quality of Life in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated in Japan
Ueda, Yasutaka
Obara, Naoshi
Yonemura, Yuji
Noji, Hideyoshi
Matsuda, Takahisa
Akiyama, Hirozumi
Ikezoe, Takayuki
Chiba, Shigeru
Kanda, Yoshinobu
Kawaguchi, Tatsuya
Shichishima, Tsutomu
Nakakuma, Hideki
Okamoto, Shinichiro
Nishimura, Jun-Ichi
Kanakura, Yuzuru
Ninomiya, Haruhiko
[J]. BLOOD, 2017, 130
[4] Correction to: Effects of eculizumab treatment on quality of life in patients with paroxysmal nocturnal hemoglobinuria in Japan
Yasutaka Ueda
Naoshi Obara
Yuji Yonemura
Hideyoshi Noji
Masayoshi Masuko
Yoshinobu Seki
Katsuya Wada
Takahisa Matsuda
Hirozumi Akiyama
Takayuki Ikezoe
Shigeru Chiba
Yoshinobu Kanda
Tatsuya Kawaguchi
Tsutomu Shichishima
Hideki Nakakuma
Shinichiro Okamoto
Jun-ichi Nishimura
Yuzuru Kanakura
Haruhiko Ninomiya
[J]. International Journal of Hematology, 2018, 108 : 233 - 235
[5] Vaccination of patients with paroxysmal nocturnal hemoglobinuria under eculizumab treatment
Rodriguez-Garcia, Juan
Fernandez-Santos, Rafael
Antonio Garcia-Erce, Jose
[J]. MEDICINA CLINICA, 2012, 138 (14): : 640 - 641
[6] Eculizumab Treatment Improves Outcomes of Pregnancy in Patients with Paroxysmal Nocturnal Hemoglobinuria
Kelly, Richard J.
Hoechsmann, Britta
Kulasekararaj, Austin
de Guibert, Sophie
Roeth, Alexander
Weitz, Ilene C.
Armstrong, Elina
Hill, Anita
Risitano, Antonio M.
Patriquin, Christopher J.
Terriou, Louis
Muus, Petra
Turner, Michelle P.
Schrezenmeier, Hubert
Szer, Jeffrey
de latour, Regis Peffault
[J]. BLOOD, 2014, 124 (21)
[7] FDA Report: Eculizumab (Soliris®) for the Treatment of Patients with Paroxysmal Nocturnal Hemoglobinuria
Dmytrijuk, Andrew
Robie-Suh, Kathy
Cohen, Martin H.
Rieves, Dwaine
Weiss, Karen
Pazdur, Richard
[J]. ONCOLOGIST, 2008, 13 (09): : 993 - 1000
[8] Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria (vol 384, pg 1028, 2021)
Calac, Alec J.
Gasca, Luis R.
Swain, William H.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (11): : 1060 - 1060
[9] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria (vol 25, pg 1256, 2007)
Rother, Russell P.
Rollins, Scott A.
Mojcik, Christopher F.
Brodsky, Robert A.
Bell, Leonard
[J]. NATURE BIOTECHNOLOGY, 2007, 25 (12) : 1488 - 1488
[10] COST BURDEN OF BREAKTHROUGH HEMOLYSIS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA ON ECULIZUMAB TREATMENT
Tomazos, I
Sierra, R.
Cheung, A.
Brodsky, R.
Weitz, I
Johnston, K.
[J]. VALUE IN HEALTH, 2019, 22 : S376 - S376

← 1 2 3 4 5 →